Click here to read the Cover Story “Specialists navigate changing, challenging landscape of geographic atrophy management.”
More knowledge about the diagnosis and management of geographic atrophy is important for every eye doctor.
We now have two FDA-approved drugs using intravitreal injection of complement inhibitors, Syfovre (pegcetacoplan injection, Apellis) and Izervay (avacincaptad pegol intravitreal solution, Astellas), that can delay progression of the disease. In the following paragraphs, I will share a few insights that I hope will be useful to the comprehensive ophthalmologist.
Dry